Cash, Cash Equivalents And Restricted Cash

3 Months Ended

Mar. 31, 2020

Cash, Cash Equivalents and Restricted Cash [Abstract]

Cash, Cash Equivalents and Restricted Cash

(5)     Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows:

	As of March 31,		As of December 31,
(in thousands)	2020		2019
Cash and cash equivalents available for general corporate purposes	$	80,904	$	43,760
Joint venture cash and cash equivalents		117,218		149,925
Cash and cash equivalents		198,122		193,685
Restricted cash		5,956		8,416
Total cash, cash equivalents and restricted cash	$	204,078	$	202,101

Cash equivalents include short-term, highly liquid investments with maturities of three months or less when acquired. Cash and cash equivalents consist of amounts available for the Company’s general purposes, the Company’s proportionate share of cash held by the Company’s unconsolidated joint ventures and 100% of amounts held by the Company’s consolidated joint ventures. In both cases, cash held by joint ventures is available only for joint venture-related uses, including future distributions to joint venture partners.

Amounts included in restricted cash are primarily held as collateral to secure insurance-related contingent obligations, such as insurance claim deductibles, in lieu of letters of credit.